Try our beta test site

Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults (PRIMALVAC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Institut National de la Santé Et de la Recherche Médicale, France
Sponsor:
Collaborators:
EVI
CIC COCHIN
CNRFP
EUCLID
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT02658253
First received: January 7, 2016
Last updated: March 23, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)